Catalyst Wire Dossier Catalyst Wire Dossier

Lamivudine Teva Pharma B.V.

lamivudine · Teva B.V.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Lamivudine Teva Pharma B.V., covering 2023-04-21 to 2023-04-21. Get the full timeline:

Most recent: EMA Authorised: Lamivudine Teva Pharma B.V. (lamivudine) — Teva B.V.

See pricing